WallStreetZenWallStreetZen

NASDAQ: VMD
Viemed Healthcare Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their VMD stock forecasts and price targets.

Forecast return on equity

Is VMD forecast to generate an efficient return?

Company
17.82%
Industry
20.77%
Market
340.19%
VMD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VMD forecast to generate an efficient return on assets?

Company
11.76%
Industry
11.68%
VMD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VMD earnings per share forecast

What is VMD's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.37+5.34%
Avg 2 year Forecast
$0.52+47.17%
Avg 3 year Forecast
$0.63+78.91%
VMD's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

VMD revenue forecast

What is VMD's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$269.2M+5.66%
Avg 2 year Forecast
$316.2M+24.09%
Avg 3 year Forecast
$387.8M+52.22%
VMD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VMD earnings growth forecast

How is VMD forecast to perform vs Medical Devices companies and vs the US market?

Company
20.03%
Industry
17.01%
Market
104.45%
VMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
VMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
VMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

VMD revenue growth forecast

How is VMD forecast to perform vs Medical Devices companies and vs the US market?

Company
12.73%
Industry
7.79%
Market
58.58%
VMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VMD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
VMD$7.22N/AN/A
SMLR$17.97$80.25+346.58%Strong Buy
SNWV$31.51N/AN/A
SENS$6.85$11.00+60.58%Strong Buy
SI$14.37$20.60+43.35%Strong Buy
View Top Medical Device Stocks

Viemed Healthcare Stock Forecast FAQ

What is VMD's earnings growth forecast for 2025-2027?

(NASDAQ: VMD) Viemed Healthcare's forecast annual earnings growth rate of 20.03% is forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 17.01%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 104.45%.

Viemed Healthcare's earnings in 2025 is $13,611,000.On average, 3 Wall Street analysts forecast VMD's earnings for 2025 to be $14,017,202, with the lowest VMD earnings forecast at $13,412,718, and the highest VMD earnings forecast at $14,769,957. On average, 3 Wall Street analysts forecast VMD's earnings for 2026 to be $19,583,024, with the lowest VMD earnings forecast at $17,138,472, and the highest VMD earnings forecast at $22,354,529.

In 2027, VMD is forecast to generate $23,806,813 in earnings, with the lowest earnings forecast at $23,099,680 and the highest earnings forecast at $24,749,657.

If you're new to stock investing, here's how to buy Viemed Healthcare stock.

What is VMD's revenue growth forecast for 2025-2027?

(NASDAQ: VMD) Viemed Healthcare's forecast annual revenue growth rate of 12.73% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.58%.

Viemed Healthcare's revenue in 2025 is $254,794,000.On average, 3 Wall Street analysts forecast VMD's revenue for 2025 to be $10,235,180,923, with the lowest VMD revenue forecast at $9,728,022,043, and the highest VMD revenue forecast at $10,857,914,239. On average, 3 Wall Street analysts forecast VMD's revenue for 2026 to be $12,020,501,835, with the lowest VMD revenue forecast at $10,957,521,156, and the highest VMD revenue forecast at $13,253,042,380.

In 2027, VMD is forecast to generate $14,744,865,051 in revenue, with the lowest revenue forecast at $14,306,898,762 and the highest revenue forecast at $15,328,820,102.

What is VMD's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: VMD) forecast ROA is 11.76%, which is higher than the forecast US Medical Devices industry average of 11.68%.

What is VMD's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: VMD) Viemed Healthcare's current Earnings Per Share (EPS) is $0.35. On average, analysts forecast that VMD's EPS will be $0.37 for 2025, with the lowest EPS forecast at $0.35, and the highest EPS forecast at $0.39. On average, analysts forecast that VMD's EPS will be $0.52 for 2026, with the lowest EPS forecast at $0.45, and the highest EPS forecast at $0.59. In 2027, VMD's EPS is forecast to hit $0.63 (min: $0.61, max: $0.65).

What is VMD's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: VMD) forecast ROE is 17.82%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.